Author:
Park Seung Ha,Bang Chang Seok,Kim Dong Joon
Reference323 articles.
1. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework;Biomarkers Definitions Working Group;Clin. Pharmacol. Ther.,2001
2. Biomarkers of liver fibrosis;Suk;Adv. Clin. Chem.,2013
3. Surrogate end points in clinical trials: are we being misled?;Fleming;Ann. Intern. Med.,1996
4. EASL recommendations on treatment of hepatitis C 2014;European Association for the Study of the Liver;J. Hepatol.,2014
5. Recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org/, 2014 (accessed on 27.11.2014).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献